Latest News – Page 2 – George Clinical

George Clinical Partners with Medidata to Unlock Operational Efficiency in Clinical Trials

Medidata, a Dassault Systèmes company, recently announced George Clinical is implementing Medidata’s cloud-based clinical solutions – Rave Grants Manager – to improve tracking and management of budgets. Medidata’s solution will also empower George Clinical to bring operational efficiency and improve patient recruitment by sites. The implementation will give George Clinical’s global clients the usage of […]

July 10th, 2023

George Clinical and EPS Collaborate on Important HR+/HER2- Breast Cancer Study in Asia Pacific

SYDNEY, June 27, 2023 – George Clinical and EPS Corporation (EPS), a global CRO based in Japan are collaborating on a rare Japanese academia-led global study seeking to advance treatments for unmet needs in Asian populations. In 2019 George Clinical and EPS formed a strategic partnership to help expand their operations across the Asia-Pacific region. […]

June 27th, 2023

Emerging Countries Offer Access to Diverse Patient Populations, Cost Savings and the Opportunity to Advance Equity in Clinical Research

By admin
CMO Corner

Having recently attended the World Congress of Nephrology (WCN) in Bangkok, Thailand, George Clinical representatives had the opportunity to meet experts and peers from around the world to share ideas and best practices and continue to develop networks that will advance global kidney health. Connecting with communities from different parts of the world not only highlights […]

June 21st, 2023

George Clinical Wins Clinical Research Team of the Year from Citeline

George Clinical recently received the award for Clinical Research Team of the Year at the 7th Annual Citeline Awards held in Boston, MA. As a 2023 winner, the George Clinical team won recognition for a multi-site program in the Asia Pacific region that recruited more than 3,000 patients across 14 sites in just seven weeks. […]

May 12th, 2023

George Clinical Applauded by Frost & Sullivan for Its Competitive Differentiation and Leadership in Strategy Execution in the Asia Pacific region

Frost & Sullivan studied the contract research organization industry and, based on its findings, recognizes George Clinical with the 2023 Asia-Pacific Competitive Strategy Leadership Award. George Clinical is a global CRO with world class expertise in kidney research, oncology and neurology and remains fully committed to growing their strong presence in Asia-Pacific which is where the company has […]

May 12th, 2023

George Clinical Selected as CRO for Hummingbird Bioscience’s Phase 1 Oncology Trials in Australia

SYDNEY, May 4, 2023 – George Clinical announces that the company has initiated preparations in Australia for two oncology Phase 1b trials that will examine a Hummingbird Bioscience precision therapy program targeting HER3, a potent driver of tumor growth and resistance against cancer drugs, in biomarker-selected patient populations, including lung cancer. George Clinical is providing […]

May 4th, 2023

Biomarkers Will Drive Future Diagnosis and Treatment of Kidney Disease

By admin
CMO Corner

A deeper understanding of disease mechanisms will help address a growing global problem. Chronic kidney disease (CKD) is a global health crisis with an estimated 850 million people affected worldwide. Rising faster than all non-infectious diseases including cardiovascular disease, CKD is 20 times more prevalent than cancer. Most people don’t even realize their kidneys are […]

March 24th, 2023

George Clinical and Trinity Care Foundation Collaborate to Provide Hearing and Assistive Aids in India

By admin
Corporate News

As part of our Corporate Social Responsibility (CSR) initiative, George Clinical India in collaboration with Trinity Care Foundation (an NGO) intends to distribute Hearing Aids for Hearing Impaired Children & Assistive Aids for Children with Disabilities from the marginalized sections of the community. Hearing loss can affect a child’s ability to develop communication, language, and […]

March 21st, 2023

George Clinical’s Participation in a Large-Scale Global Program Helped Lead GSK Oral Anemia Drug to Gain Partial FDA Approval

By admin
Corporate News

Fierce Pharma recently reported that GSK’s oral anemia drug, Jesduvroq, has scored partial FDA approval after two rivals previously suffered rejections. George Clinical’s global and national scientific leadership helped move the breakthrough CKD anemia treatment forward via the collaboration between the organization’s exceptional kidney and metabolic scientific leadership network and GSK. The network provided continuity, […]

February 22nd, 2023

George Clinical to Accelerate International Growth Through Acquisition by Hillhouse

By admin
Corporate News

SYDNEY, December 9, 2022 – George Clinical announces that it has entered into a sale agreement with Hillhouse, a global investment firm with deep experience in partnering with and supporting healthcare businesses. The transaction will allow George Clinical to continue a path of rapid global expansion, leadership in Asia-Pacific clinical research services, and will provide considerable […]

December 9th, 2022